Organic Active Ingredients TRIZ Cases

Adding lixisenatide to existing insulin glargine and metformin regimens resolves inadequate glycemic control by improving HbA1c levels.

Formic acid mediates solubility of basic drugs in volatile solvents, enabling stable amorphous solid dispersions at modest temperatures.

Arylene compounds inhibit p38 MAPK activity via inhalation, resolving the trade-off between therapeutic duration and pulmonary deliverability.

Extracting phorbol intermediates from Croton tiglium seeds overcomes geographical supply constraints for scalable tigilanol tiglate production.

Allosteric binding overcomes orthosteric conservation limits, enabling selective mGlu2 modulation for neurological disorders.

Novel N-substituted ferroportin inhibitors block iron transport to prevent tissue overload while reducing toxicity associated with chelation therapies.

A faecal mimic composition restores functional faeces production in patients with temporary derivative ileostomy.

Ion exchange resin-bound phenylephrine prevents premature release and interaction issues in modified release analgesic suspensions.

Substituted 4-fluoro-2,5-dihydrofuranyl phosphonic acid inhibits LINE1 and HERV-K reverse transcriptases to treat medical disorders.

6-ETI nucleoside analogs exploit elevated adenosine kinase activity to selectively destroy tumor cells while sparing normal tissue.

Combining CpG-oligodeoxynucleotides with immune checkpoint inhibitors activates TLR9 receptors to stimulate anti-tumor immunity.

Penetration enhancers facilitate drug transport through the stratum corneum barrier, resolving hydrophobic solubility limits.

Aziridinyl dimeric naphthoquinones overcome drug resistance by combining oxidative stress induction with direct DNA alkylation to inhibit cell proliferation.

Chemically modified siRNA molecules down-regulate KRAS mRNA to overcome acquired resistance in refractory cancers.

Co-administering cytokine signaling immunomodulators with antigen-carrier conjugates boosts germinal center formation and IgG2a/IgG3 antibody concentrations.

Optimized oral liquid chlorpromazine formulation maintains stability and reduces impurity generation for pediatric and geriatric patients.

Nanoclusters aggregate nanoparticles into controlled aerodynamic structures to resolve lung deposition and industrial handling contradictions.

Slow-dissolving soft lozenges deliver sustained topical corticosteroids to the esophagus, avoiding variable inhalation doses and systemic absorption risks.

Amino acid compositions mitigate radiation-induced gastrointestinal toxicity while maintaining cancer cell destruction efficacy.

Optimizing pharmaceutical stability and efficacy through selected polymorphs overcomes complex immune-suppressive pathways.

GPBP-1 inhibitors block kinase and chaperone activities to prevent insulin resistance in type 2 diabetes.

Quinoline carboxamide derivatives inhibit protein tyrosine kinases through targeted molecular design.

A CNS homing peptide conjugates psilocybin to target specific central nervous system regions, reducing non-specific distribution and side effects.

PROTAC compounds recruit E3 ligases to degrade RIP2 kinase, overcoming limited efficacy of traditional small molecule inhibitors.

L-Ergothioneine prevents age-related visual degeneration by activating endogenous antioxidant pathways and inhibiting oxidation-induced fibrosis.

Thapsigargin-treated tumor cells stimulate host immunity to destroy cancer while avoiding systemic toxicity.

Human milk oligosaccharides stimulate beneficial gut bacteria to reduce inflammation and improve bowel regularity in renal disease patients.

A benzyloxy pyridine derivative induces p62 protein oligomerization to activate selective autophagy.

A compound binds to heat shock protein 60 and inhibits ClpP interaction.

Oral dissolvable dosage form combines cranberry extract and vitamin C for gingivitis treatment.

Novel 5,6-fused bicyclic compounds inhibit kinetoplastid parasite growth via targeted proteasome interference.

Hexyldecanol counteracts glycerin's retarding effect on niacinamide, increasing skin layer recovery rates.

Substituted aromatic compounds target the HCV NS5A phosphoprotein to inhibit viral replication in drug-resistant strains.

Novel aromatic ring-fused lactam compounds inhibit ERK1/2 kinase activity at low concentrations.

A biomarker composition measuring AURKA and MYC gene expression levels predicts therapeutic response to anticancer drugs.

Rosemarinic acid complexes with elderberry anthocyanins to prevent degradation and boost oral bioavailability for pharmaceutical use.

Sugar alcohol crosslinkers enable site-specific conjugation of therapeutic agents through selective hydroxyl reactivity.

Ultra-high pressure dispersion produces pure hyaluronic acid nanoparticles without organic solvents, overcoming structural modification and low yield issues.

Covalently bonded chelators sequester cobalt and nickel ions to reduce metallosis toxicity without invasive implant removal surgery.

Novel isosorbide-based compounds release nitric oxide at the endothelial surface to induce localized vasodilation.

An aqueous ivermectin nano-suspension with Tween 80 stabilizes particles below 600 nm, enabling safe inhalation without organic solvent irritation.

Droplet solidification forms core-shell particles with small diameters, avoiding complex multi-step coating processes that increase size.

Pentameric, trimeric, and tetrameric procyanidins inhibit viral entry across genotypes, preventing re-infection after liver transplantation.

Solid dosage forms combine four antiviral compounds with stabilizing polymers to enhance bioavailability.

Disubstituted 5-fluoro pyrimidine derivatives with a sulfoximine group target the CDK9/Cyclin T1 kinase complex.

Sodium citrate, vitamin C, and L-lysine bind calcium ions in plaque to remove hard deposits without invasive surgery or harmful side effects.

Optimized heterocyclic structures inhibit TGFbetaR1 kinase activity, addressing inadequate treatment for cancer and fibrosis.

Benzimidazolyl isoxazole compounds modulate p300 and CBP acetyltransferase activity to treat castration-resistant prostate cancer.

Substituted thiophene compounds selectively target the p38α MAPK pathway to reduce inflammation while avoiding gastrointestinal side effects of NSAIDs.

Composite marine lipid structure improves tissue incorporation of omega-3 fatty acids while reducing inflammatory biomarkers in pathological conditions.

Tapentadol treats trigeminal neuralgia via dual pharmacological action, reducing side effects while maintaining efficacy.

PXT002331 chromone oxime derivative acts as a positive allosteric modulator of mGluR4 receptors.

Specific pyrazole derivatives activate soluble guanylate cyclase to elevate cGMP levels, preventing tolerance development and reducing required dosages.

Detect FGFR3-TACC3 fusion genes using specific primer sets to identify patients for targeted inhibitor therapy.

Radiolabeled compounds bind selectively to amyloid deposits and tau aggregates, enabling early detection of Alzheimer's disease pathology.

Pre-polymerized tannins using aldehydes eliminate oxidative aging time while preventing premature oxidation and preserving fruit aroma.

Amine-containing flavonoid monomers enable oral therapy by improving bioavailability and reducing nephrotoxicity compared to parenteral treatments.

A liposome vaccine composition encapsulates antigen and polyI:C within a hydrophobic carrier continuous phase.

Retinoic acid receptor gamma agonists repress TOP2B and activate ERK pathways to minimize cardiac damage during anthracycline chemotherapy.

Substituted pyrido-naphthyridine compounds overcome drug resistance in cancer cells by optimizing binding affinity to the CK2 enzyme.

Combines SHP2 and PD-1 inhibitors to overcome immune checkpoint resistance and improve clinical response rates.

Adjusting mifepristone dosages to 75-300 mg improves reliability for women with unfavorable cervix conditions while maintaining fetal safety.

ML 141 binds directly to CDC42, preventing GTP-loading and reducing intracellular persistence of Staphylococcus aureus.

Substituted phenothiazine derivatives activate glucokinase to improve glucose utilization and lower blood sugar levels in diabetic patients.

GSK3B inhibitors activate the WNT pathway to promote melanocyte stem cell differentiation and repigment skin.

Nucleic acid expression signatures identify fibromyalgia by measuring specific gene levels, resolving diagnostic precision limits of physical assessments.

Formula I compounds inhibit viral antigen release from infected hepatocytes, reducing hepatitis B surface antigen levels and promoting immunological control.

Bupropion hydrobromide modified release tablets utilize SMARTCOAT technology to deliver controlled drug release profiles.

A heterocyclic derivative acts as a PGI2 receptor agonist to treat spinal canal stenosis symptoms.

Propellant-driven metered-dose device delivers dry olanzapine powder through nasal mucosa, achieving fast plasma exposure without injection trauma.

Heat treating guava leaf extract at 100 to 180°C dissolves insoluble ellagic acid, preventing precipitation and maintaining flavor.

Dihydroquinolizinone derivatives reduce persistent HBsAg levels by inhibiting viral replication, addressing immune suppression in chronic carriers.

Butylphthalide intravenous emulsion bypasses first pass metabolism to enhance bioavailability and enable treatment for dysphagia patients.

Segmented synthesis routes for chiral sulfamate intermediates enable precise stereochemical control during cyclopentyl ring formation.

Non-covalent polymer dispersion on neutral lipid membranes adsorbs biomaterials, avoiding chemical modification degradation and complex purification steps.

Specific aspartic acid and tyrosine ratios elevate blood pH and decompose lactic acid to enhance intermittent endurance capacity.

SDS-PAGE urine protein analysis detects high molecular weight markers, replacing invasive renal biopsy to reduce patient risk and cost.

Nanoparticulate erlotinib formulations maintain consistent pharmacokinetic profiles across fed and fasted states by reducing particle size below 2000 nm.

Acyl sulfonamide compounds target NaV1.7 voltage sensor residues to achieve high selectivity, reducing side effects from non-selective inhibition.

Multiple functional layers with distinct pH thresholds expand the operating range for reliable drug delivery, accommodating intestinal pH fluctuations.

High-dose glycine enhances NMDA receptor signaling to reduce OCD symptoms while arginine minimizes gastrointestinal side effects.

Modified oligonucleotides reduce WFDC2 mRNA levels, validating therapeutic efficacy across ovarian and gastric cancer models.

A dual extended-release pregabalin composition uses hydroxypropyl cellulose and ethyl cellulose to control drug release kinetics.

Inhibition of the TFPI2-CD51-STAT6 signaling axis targets glioblastoma stem cells to overcome treatment resistance and enhance antitumor immune responses.

Combines MAT2A and Type I PRMT inhibitors to reduce adverse side effects in normal tissues.

A gastro-resistant composition delivers Vaccinium extract to the colon via a protective film shell.

Pre-screening SLC6A4 polymorphisms predicts disulfiram responsiveness and adverse events, improving compliance by tailoring therapy.

2-Aminothiazole derivatives simultaneously inhibit acetylcholine esterase, PARP-1, and MyD88 signaling to address multi-factorial Alzheimer's pathology.

A usnic acid derivative inhibits TSLP secretion to modulate immune responses in skin treatments.

Antisense oligonucleotides bind natural antisense transcripts to modulate IQGAP expression, resolving specificity and efficiency trade-offs.

Forskolin emulsion with castor oil stimulates eyelash growth while avoiding synthetic preservative side effects.

A 0.5% brimonidine tartrate gel treats telangiectasia symptoms through localized vasoconstriction.